COBAS® SARS-COV-2 & INFLUENZA A/B
Received Sep 6, 2024 · Event occurred Aug 2, 2024
Report 2243471-2024-02591 · MDR key 20163342
Device
Generic name
Multi-target Resp Specimen Nat Incl. Sars-cov-2 & Other Microbial Agents
Manufacturer
Roche Molecular Systems, Inc. - BranchburgCatalog number
09211101190
Lot number
40311E
Product problems
- Non Reproducible Results
- Non Reproducible Results
Patient
37 YR · Male
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
THE SERIAL NUMBER OF THE COBAS® LIAT® ANALYZER IS (B)(6). THE AFFECTED RUN DATA COULD NOT PROVIDED FOR REVIEW AND ANALYSIS. THE REAGENT INVESTIGATION DID NOT IDENTIFY A SYSTEMIC PRODUCT PROBLEM. THE EXACT ROOT CAUSE OF THE ISSUE REMAINS UNKNOWN.
Description of Event or Problem
THERE WAS AN ALLEGATION OF QUESTIONABLE SARS-COV-2 RESULT FOR A PATIENT SAMPLE USING COBAS® SARS-COV-2 & INFLUENZA A/B FOR USE ON THE COBAS® LIAT® SYSTEM. THE ALLEGED SAMPLE INITIALLY GENERATED A POSITIVE RESULT FOR SARS-COV-2 (NEGATIVE FOR INFLUENZA A/B). THE SAME SAMPLE WAS REPEATED ON A COMPETITOR ASSAY (GENEXPERT) AND WAS NEGATIVE. THE REPEAT RESULT WAS DEEMED CORRECT, AND THE PATIENT'S RESULT WAS REPORTED AS NEGATIVE.